SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-050159
Filing Date
2021-04-14
Accepted
2021-04-14 14:41:27
Documents
12
Period of Report
2021-04-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2113007d1_8k.htm   iXBRL 8-K 27074
  Complete submission text file 0001104659-21-050159.txt   199277

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ocgn-20210414.xsd EX-101.SCH 3196
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocgn-20210414_lab.xml EX-101.LAB 34592
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocgn-20210414_pre.xml EX-101.PRE 22717
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2113007d1_8k_htm.xml XML 3485
Mailing Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355
Business Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355 484-328-4698
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 21825440
SIC: 2836 Biological Products, (No Diagnostic Substances)